Product Details for NDA 050589
CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER (CEFTIZOXIME SODIUM)
EQ 20MG BASE/ML
Marketing Status: Discontinued
EQ 40MG BASE/ML
Marketing Status: Discontinued
EQ 20MG BASE/ML
Marketing Status: Discontinued
EQ 40MG BASE/ML
Marketing Status: Discontinued
EQ 20MG BASE/ML
Marketing Status: Discontinued
Active Ingredient: CEFTIZOXIME SODIUM
Proprietary Name: CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050589
Product Number: 001
Approval Date: Oct 3, 1984
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER (CEFTIZOXIME SODIUM)
Proprietary Name: CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050589
Product Number: 001
Approval Date: Oct 3, 1984
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 40MG BASE/ML
Marketing Status: Discontinued
Active Ingredient: CEFTIZOXIME SODIUM
Proprietary Name: CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050589
Product Number: 002
Approval Date: Oct 3, 1984
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
CEFIZOX IN PLASTIC CONTAINER (CEFTIZOXIME SODIUM)
Proprietary Name: CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050589
Product Number: 002
Approval Date: Oct 3, 1984
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 20MG BASE/ML
Marketing Status: Discontinued
Active Ingredient: CEFTIZOXIME SODIUM
Proprietary Name: CEFIZOX IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050589
Product Number: 003
Approval Date: Apr 13, 1995
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
CEFIZOX IN PLASTIC CONTAINER (CEFTIZOXIME SODIUM)
Proprietary Name: CEFIZOX IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050589
Product Number: 003
Approval Date: Apr 13, 1995
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 40MG BASE/ML
Marketing Status: Discontinued
Active Ingredient: CEFTIZOXIME SODIUM
Proprietary Name: CEFIZOX IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050589
Product Number: 004
Approval Date: Apr 13, 1995
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CEFIZOX IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050589
Product Number: 004
Approval Date: Apr 13, 1995
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status: Discontinued
Patent and Exclusivity Information